Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Chen

Showing results (471-480 of 507) with videos related to

Pageof 51
Sort By:
European Urology Oncology|March 14, 2020
Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder CancerBenjamin Miron, Jean H Hoffman-Censits, Fern Anari, et al.
The Lancet. Oncology|April 19, 2014
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trialFabrice André, Ruth O'Regan, Mustafa Ozguroglu, et al.
Science Translational Medicine|October 15, 2020
Tissue engineered autologous cartilage-bone grafts for temporomandibular joint regenerationDavid Chen, Josephine Y Wu, Kelsey M Kennedy, et al.
Plos One|March 4, 2014
Clinical validation of a PCR assay for the detection of EGFR mutations in non-small-cell lung cancer: retrospective testing of specimens from the EURTAC trialSusana Benlloch, Maria Luisa Botero, Jordi Beltran-Alamillo, et al.
NPJ Precision Oncology|May 6, 2024
Author Correction: Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targetingAurel Prosz, Pranshu Sahgal, Brandon M Huffman, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 24, 2024
Nuclear Control of Mitochondrial Homeostasis and Venetoclax Efficacy in AML via COX4I1Leisi Zhang, Honghai Zhang, Ting-Yu Wang, et al.
NPJ Precision Oncology|April 8, 2024
Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targetingAurel Prosz, Pranshu Sahgal, Brandon M Huffman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2021
Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic <i>ROS1</i> Fusion-Positive Non-Small-Cell Lung CancerRafal Dziadziuszko, Matthew G Krebs, Filippo De Braud, et al.
Nature Immunology|July 17, 2023
Induction of bronchus-associated lymphoid tissue is an early life adaptation for promoting human B cell immunityRei Matsumoto, Joshua Gray, Ksenia Rybkina, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 2, 2023
Postoperative Complications After Interpolated Flap Repair for Mohs Defects of the Nose: A Multicenter Prospective Cohort StudyAllison M Perz, Tess M Lukowiak, Michael P Lee, et al.
Pageof 51

Showing results (471-480 of 507) with videos related to

Sort By:
Pageof 51
European Urology Oncology|March 14, 2020
Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder CancerBenjamin Miron, Jean H Hoffman-Censits, Fern Anari, et al.
The Lancet. Oncology|April 19, 2014
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trialFabrice André, Ruth O'Regan, Mustafa Ozguroglu, et al.
Science Translational Medicine|October 15, 2020
Tissue engineered autologous cartilage-bone grafts for temporomandibular joint regenerationDavid Chen, Josephine Y Wu, Kelsey M Kennedy, et al.
Plos One|March 4, 2014
Clinical validation of a PCR assay for the detection of EGFR mutations in non-small-cell lung cancer: retrospective testing of specimens from the EURTAC trialSusana Benlloch, Maria Luisa Botero, Jordi Beltran-Alamillo, et al.
NPJ Precision Oncology|May 6, 2024
Author Correction: Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targetingAurel Prosz, Pranshu Sahgal, Brandon M Huffman, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 24, 2024
Nuclear Control of Mitochondrial Homeostasis and Venetoclax Efficacy in AML via COX4I1Leisi Zhang, Honghai Zhang, Ting-Yu Wang, et al.
NPJ Precision Oncology|April 8, 2024
Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targetingAurel Prosz, Pranshu Sahgal, Brandon M Huffman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2021
Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic <i>ROS1</i> Fusion-Positive Non-Small-Cell Lung CancerRafal Dziadziuszko, Matthew G Krebs, Filippo De Braud, et al.
Nature Immunology|July 17, 2023
Induction of bronchus-associated lymphoid tissue is an early life adaptation for promoting human B cell immunityRei Matsumoto, Joshua Gray, Ksenia Rybkina, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 2, 2023
Postoperative Complications After Interpolated Flap Repair for Mohs Defects of the Nose: A Multicenter Prospective Cohort StudyAllison M Perz, Tess M Lukowiak, Michael P Lee, et al.
Pageof 51